In patients with mast cell leukaemia (MCL), indolent systemic mastocytosis (ISM) and aggressive systemic mastocytosis (ASM), loss of heterozygosity (LOH) of chromosome region 3p21 leads to the loss of 10 genes, among them NBEAL2 [22]. This evidence concerns the gene NBEAL2 and systemic mastocytosis.